Improving the diagnosis and patient management of systemic autoinflammatory diseases
THE PROJECT GOALS
ImmunAID seeks new biomarkers able to identify and classify more rapidly and more accurately autoinflammatory disorders
Identify a common signature to SAID enabling rapid differential diagnosis
Provide deep characterization of each specific pathogenic pathway and build dedicated analysis kits
Build a robust algorithm enabling reliable triage among the whole SAID spectrum
12
Countries
16 M€
Funding
5
Years
25
Partners
37
Hospitals
ImmunAID
Grant agreement no: 779295
Funded under: H2020-EU.3.1.1.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 779295
Cookies infos
The website does not collect any statistical and tracking data. Requests for information through the contact form ensures the protection of personal data by guaranteeing that data collection is carried out with the informed consent of individuals
